A list of medical allergies is an essential part of every patient's health record, helping clinicians make safe prescribing and treatment decisions. In the UK, allergic conditions affect a significant proportion of the population, spanning reactions to medications, foods, insect stings, latex, and environmental triggers. Understanding which substances are recognised as medical allergens, how they are diagnosed, and how allergy information should be recorded and shared is vital for patient safety. This guide covers the most common medical allergies recognised in the UK, how they are diagnosed and managed under NHS and NICE guidance, and what to do in an emergency.

Common Medical Allergies Recognised in the UK

A list of medical allergies encompasses a wide range of substances that can trigger immune-mediated reactions in susceptible individuals. In the UK, the most commonly recorded medical allergies include reactions to medications, foods, insect stings, latex, and environmental allergens such as pollen, dust mites, and animal dander. According to Allergy UK and the British Society for Allergy and Clinical Immunology (BSACI), allergic conditions affect a substantial proportion of the UK population at some point in their lives, making accurate allergy recording a significant public health priority.

The most frequently encountered categories include:

• Drug allergies – particularly to penicillin, non-steroidal anti-inflammatory drugs (NSAIDs), and aspirin

• Food allergies – including peanuts, tree nuts, shellfish, milk, eggs, wheat, and soya

• Insect venom allergies – most commonly to bee and wasp stings

• Latex allergy – particularly relevant in healthcare and surgical settings

• Contact allergens – such as nickel, fragrances, and certain preservatives

It is important to distinguish between a true allergy, which involves an immune system response, and an intolerance or sensitivity, which does not. Many true allergies are IgE-mediated (for example, peanut or penicillin allergy), whilst allergic contact dermatitis is a T-cell–mediated (Type IV) delayed hypersensitivity reaction rather than an IgE-mediated response. By contrast, lactose intolerance is a digestive condition and not an allergy at all. Misclassification can lead to unnecessary avoidance of treatments or foods, so accurate diagnosis is essential. Healthcare professionals in the UK are guided by NICE and the BSACI when assessing and categorising allergic conditions.

How Allergies Are Diagnosed and Recorded on Your Medical Record

Allergy diagnosis in the UK typically begins with a detailed clinical history taken by a GP or specialist. The nature of the reaction, the timing, the substance involved, and any previous exposures are all carefully documented. Depending on the suspected allergen, further investigations may be recommended, including:

• Skin prick testing – a small amount of allergen is introduced to the skin to observe a localised reaction

• Specific IgE blood tests (previously known as RAST tests) – measuring antibodies to particular allergens

• Patch testing – used primarily for contact dermatitis

• Oral food challenges – conducted under medical supervision when the diagnosis is uncertain

NICE guideline CG116 provides recommendations on the diagnosis and assessment of suspected food allergy in children and young people; for adult allergy assessment, BSACI guidelines offer specialist consensus. NICE and BSACI both advise that allergy test results are interpreted alongside clinical history rather than in isolation, as false positives can occur. Once confirmed, allergies should be formally recorded on your NHS medical record using standardised coding systems such as SNOMED CT, in line with NHS England guidance on allergy and adverse reaction documentation, which helps ensure consistency across GP surgeries, hospitals, and other care settings.

Patients are encouraged to review their allergy records with their GP to ensure accuracy. An incorrectly recorded allergy — or one that has never been formally confirmed — can have significant consequences, including unnecessary avoidance of effective treatments. For instance, evidence cited in BSACI guidance on penicillin allergy de-labelling suggests that a large proportion of patients labelled as penicillin-allergic may in fact tolerate the antibiotic when formally assessed and tested. Keeping your allergy list up to date and clinically verified is therefore an important aspect of safe, personalised healthcare.

Drug and Medication Allergies: What You Need to Know

Drug allergies represent one of the most clinically significant entries on any list of medical allergies, as they can directly affect prescribing decisions across all areas of healthcare. A true drug allergy involves an immune system response to a medication or one of its components. This differs from a predictable side effect or a pharmacological intolerance, though all three should be clearly documented in a patient's records.

Common medications associated with allergic reactions include:

• Penicillin and related beta-lactam antibiotics – the most frequently reported drug allergy in the UK

• NSAIDs such as ibuprofen and aspirin – which can trigger reactions via non-IgE mechanisms

• Sulfonamide antibiotics – associated with skin reactions including Stevens–Johnson syndrome in rare cases

• Contrast media – used in imaging procedures, occasionally causing hypersensitivity reactions

• Biological therapies – increasingly relevant as their use expands across specialties

• Vaccines – true vaccine anaphylaxis is rare; assessment and management of suspected vaccine allergy should follow the UK Immunisation against Infectious Disease guidance (the Green Book) and the relevant Summary of Product Characteristics (SmPC)

The mechanism of drug hypersensitivity reactions is classified using the Gell and Coombs system (Types I–IV). Type I reactions are IgE-mediated and can cause rapid-onset anaphylaxis, whilst Type IV reactions are T-cell–mediated and typically present as delayed skin rashes. Understanding the mechanism helps clinicians determine safe alternative treatments. NICE guideline CG183 (Drug allergy: diagnosis and management) and BSACI drug allergy guidelines provide authoritative frameworks for assessment and management in the UK.

The MHRA and NHS advise that any suspected drug reaction should be reported via the Yellow Card scheme at yellowcard.mhra.gov.uk, which collects data on adverse drug reactions to support ongoing medicines safety monitoring. Patients should always inform prescribers, pharmacists, and anaesthetists of any known or suspected drug allergies before receiving new medications or undergoing procedures.

Managing Allergic Reactions: NHS Guidance and Treatment Options

The management of allergic reactions depends on their severity and the allergen involved. For mild to moderate reactions — such as localised urticaria (hives), rhinitis, or mild gastrointestinal symptoms — first-line treatment typically involves antihistamines. Non-sedating antihistamines such as cetirizine, loratadine, or fexofenadine are commonly recommended by NHS guidance and are available over the counter.

For more persistent or moderate allergic conditions, additional treatments may include:

• Topical or intranasal corticosteroids – for allergic rhinitis and eczema

• Leukotriene receptor antagonists (e.g., montelukast) – used in allergic asthma and rhinitis

• Allergen immunotherapy – a specialist treatment involving gradual exposure to an allergen to reduce sensitivity over time, available through NHS allergy clinics for selected conditions such as severe hay fever or venom allergy, in line with BSACI guidance

For individuals at risk of severe or life-threatening reactions (anaphylaxis), the NHS recommends carrying two adrenaline auto-injectors (AAIs) at all times. Several AAI devices are currently available in the UK; patients should follow their prescriber's advice and be aware that product availability may change in line with MHRA notices. Adrenaline acts rapidly to reverse the physiological effects of anaphylaxis by causing vasoconstriction, bronchodilation, and reducing vascular permeability.

In the event of suspected anaphylaxis, the Resuscitation Council UK (RCUK) advises the following emergency actions whilst awaiting 999 services: administer the AAI immediately into the outer thigh (through clothing if necessary); lie the person down with their legs raised, unless they are having difficulty breathing, in which case allow them to sit up; avoid standing or walking; administer a second AAI after five minutes if there is no improvement; and commence CPR if the person becomes unresponsive and stops breathing normally.

Patients prescribed AAIs should receive training on their correct use, and those around them — including family members, carers, and school staff — should also be familiar with the device. NICE guideline CG134 (Anaphylaxis: assessment and referral after emergency treatment) provides a clear framework for follow-up care, including referral to a specialist allergy service after any confirmed anaphylactic episode.

When to Seek Urgent Medical Help for an Allergic Reaction

Knowing when an allergic reaction requires emergency attention is a critical aspect of patient safety. Whilst many reactions are mild and self-limiting, some can escalate rapidly to anaphylaxis — a severe, potentially life-threatening systemic reaction that requires immediate medical intervention.

Call 999 immediately if any of the following symptoms occur:

• Sudden difficulty breathing, wheezing, or stridor

• Swelling of the throat, tongue, or lips

• A rapid or weak pulse

• Dizziness, collapse, or loss of consciousness

• Severe skin reactions spreading rapidly across the body

• Nausea, vomiting, or abdominal pain alongside other symptoms

It is important to note that anaphylaxis can occur without prominent skin symptoms — the absence of a rash or urticaria does not rule out a severe reaction. Anaphylaxis typically develops within minutes of exposure to a trigger, though in some cases — particularly with food allergens — onset may be delayed by up to an hour. Biphasic reactions, in which symptoms return hours after the initial episode, can also occur, which is why medical observation following anaphylaxis is important.

If an adrenaline auto-injector is available and anaphylaxis is suspected, it should be administered immediately into the outer thigh, even through clothing, whilst awaiting emergency services. The person should be laid down with their legs raised (or allowed to sit up if breathing is difficult), and a second dose given after five minutes if there is no improvement.

For reactions that are concerning but not immediately life-threatening — such as a widespread rash, mild facial swelling, or persistent urticaria — patients should contact their GP or call NHS 111 for advice. It is also important to seek medical review after any new or unexpected allergic reaction, even if it resolves on its own, so that the cause can be investigated and the allergy formally recorded. Prompt follow-up reduces the risk of a more severe reaction occurring in the future.

Sharing Your Allergy Information Safely with Healthcare Providers

Effective communication of your allergy information is a fundamental component of patient safety. In the UK, allergy data is stored within your NHS Summary Care Record (SCR), which can be accessed by authorised healthcare professionals — including out-of-hours GPs, pharmacists, and hospital staff — for the purposes of your direct care, ordinarily with your permission. In emergency situations where you are unable to give consent, authorised clinicians may access the SCR to provide safe treatment. Ensuring that this record is accurate and current is therefore essential, particularly if you have multiple allergies or have had a reaction reviewed or de-labelled following formal testing.

There are several practical steps patients can take to share allergy information safely:

• Inform all healthcare providers at every appointment, including dentists, pharmacists, and hospital teams, even if the information is already on your record

• Carry a written allergy list or use a medical alert card or bracelet, particularly for severe or life-threatening allergies

• Update your GP promptly if you experience a new reaction or if a previously recorded allergy has been formally reassessed

• Use NHS-approved digital tools where available, such as the NHS App, which allows patients to view elements of their health record including recorded allergies

For patients with complex allergy histories, a letter from a specialist allergy clinic summarising confirmed allergies, reaction types, and safe alternatives can be invaluable — particularly when attending unfamiliar healthcare settings or travelling abroad. The MHRA and NHS England both support standardised allergy documentation, including the use of SNOMED CT coding, as part of broader medicines safety and interoperability initiatives.

Ultimately, a well-maintained and clearly communicated list of medical allergies protects patients from avoidable harm and enables healthcare professionals to make informed, safe prescribing and treatment decisions at every point of care.

Frequently Asked Questions